Glaukos to Present Multiple Abstracts at ASCRS 2026

At the ASCRS Annual Meeting in Washington, D.C. (April 10–13, 2026), Glaukos plans to present glaucoma-focused presentations and posters on trabecular micro-bypass stents and a travoprost intracameral implant, along with cornea-focused items related to Epioxa and keratoconus screening.

One oral presentation will include 12-month outcomes for standalone third-generation trabecular micro-bypass stents in eyes with open-angle glaucoma, while others will include outcomes at 1 month for stents paired with a travoprost intracameral implant with or without cataract surgery, and 2-year outcomes after third-generation stent implantation performed with phacoemulsification.

A separate poster will describes 3-month outcomes for a travoprost intracameral implant used in combination with a trabecular micro-bypass system.